Nykaa has faced massive selloff off late as Street dumped shares of richly valued new-age companies against the backdrop of Fed rate hikes,...

Net revenue, however, rose to Rs 399.19 crore in the third quarter as compared with Rs 310.26 crore in the same period of 2020-21, Morepen ...

The 18,100 level for Nifty50 would be the key to watch out for

Gaurav Ratnaparkhi, Head of Technical Research, Sharekhan by BNP Paribas said With Thursday's bounce the Nifty50 has once again tested the ...

The smallcap pharma scrip has been thumping rock and roll over the past few weeks.

Confirmed Covid-19 cases in India rose above 18 million with a record rise in infections and deaths over the last 24 hours.

Hindustan Unilever, Titan and Bajaj Auto, Ambuja Cements, Motherson Sumi, Bajaj Holdings, Shriram Transport, AU SFB, IndiaMart InterMesh an...

So far this week, Nectar Life has gained 36 per cent, Morepen has risen 30 per cent, Panacea has moved up 28 per cent Suven Life has advanc...

“We maintain our cautious stance for the markets in the near term as increasing restriction would adversely impact economic activities,” sa...

Its consolidated total revenue stood at Rs 208.38 crore for the quarter under consideration.

Company as well as sector-specific developments mainly drove a couple of stocks.

Brokerages turned cautious on the sector just ahead of September quarter earnings.

Nifty Pharma index outpaced the benchmark index which slipped more than 1 per cent.

Here's a look at the top stocks that are likely to hog limelight in today's trading session.

The Sensex rallied over 340 points, and Nifty breached the 11,200 mark for the first time today.

BSE Healthcare index was one of the biggest laggards of 2016, with many stocks losing over 40% during the period, including Orchid Chemical...

Every week, an expert selected by ET answers queries from our readers on stocks